0:00
/
Generate transcript
A transcript unlocks clips, previews, and editing.

AEM Just Jumped 14%. My Forensic Zone Actually Changed Too

A blowout 1H2026 and a restored dividend just pushed AEM's yield above my 3.2% floor.

AEM just forced me to change a forensic call I had kept in the red zone. First half 2026 revenue rose almost 30% to S$247 million, while net profit surged 876% to S$30.8 million, and a restored dividend pushed the provisional yield above my 3.2% floor. I explain what changed, why the 4.7% hurdle still matters, and why the answer looks very different for an existing shareholder than someone entering at Thursday’s S$11 price. Iggy’s Forensic Zone: Zone 4, Caution.

Key takeaways:

  • Revenue rose almost 30% to S$247 million.

  • Net profit jumped 876% to S$30.8 million.

  • AEM declared a 2.4 cent interim dividend.

  • The combined 3.7 cent payout implies roughly a 3.3% yield.

  • The 4.7% hurdle still sits above AEM’s current yield.

This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.


Iggy’s Forensic Disclaimer

This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.

Discussion about this video

User's avatar

Ready for more?